Terms: = Prostate cancer AND NF2, ACN, 4771, ENSG00000186575, P35240, SCH, Merlin, BANF AND Diagnosis
4 results:
1. The Identification and Analysis of MicroRNAs Combined Biomarkers for Hepatocellular Carcinoma diagnosis.
Shi Y; Men J; Sun H; Tan J
Med Chem; 2022; 18(10):1073-1085. PubMed ID: 35379158
[TBL] [Abstract] [Full Text] [Related]
2. [Evaluation of the PI-RADSv2 classification in a cohort of patients who underwent a prostate fusion biopsy.].
Rodríguez Cabello MÁ; Sanz Migueláñez JL; Méndez Rubio S; Arias Fúnez F; Garrido Abad P; Carrillo Guivernau MJ; Velasco Ruíz M; González Gordaliza C; Platas Sancho A
Arch Esp Urol; 2020 Jan; 73(1):1-10. PubMed ID: 31950917
[TBL] [Abstract] [Full Text] [Related]
3. Non-steroidal anti-inflammatory drug use and the risk of benign prostatic hyperplasia-related outcomes and nocturia in the prostate, Lung, Colorectal, and Ovarian cancer Screening Trial.
Sutcliffe S; Grubb Iii RL; Platz EA; Ragard LR; Riley TL; Kazin SS; Hayes RB; Hsing AW; Andriole GL;
BJU Int; 2012 Oct; 110(7):1050-9. PubMed ID: 22429766
[TBL] [Abstract] [Full Text] [Related]
4. PSMA expression in schwannoma: a potential clinical mimicker of metastatic prostate carcinoma.
Wang W; Tavora F; Sharma R; Eisenberger M; Netto GJ
Urol Oncol; 2009; 27(5):525-8. PubMed ID: 18534872
[TBL] [Abstract] [Full Text] [Related]
